{"result": {"id": "6dcf4e60-0329-4478-8d09-59d1f7591758", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS<|>ORGANIZATION<|>Non-vitamin K antagonist oral anticoagulants are preferred for non-valvular atrial fibrillation patients according to guidelines\")\n##\n(\"entity\"<|>HYPERTENSION<|>EVENT<|>Hypertension is a major risk factor for atrial fibrillation and also increases stroke and bleeding risks in AF patients\")\n##\n(\"entity\"<|>STROKE<|>EVENT<|>Stroke is a potential complication of atrial fibrillation that anticoagulation therapy aims to prevent\")\n##\n(\"entity\"<|>THROMBOEMBOLISM<|>EVENT<|>Thromboembolism is a key risk in atrial fibrillation patients that requires anticoagulation therapy\")\n##\n(\"entity\"<|>BLEEDING<|>EVENT<|>Bleeding is a major risk factor to assess when considering anticoagulation therapy for atrial fibrillation\")\n##\n(\"relationship\"<|>NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS<|>ATRIAL FIBRILLATION<|>NOACs are the preferred anticoagulants for non-valvular AF patients<|>9)\n##\n(\"relationship\"<|>HYPERTENSION<|>ATRIAL FIBRILLATION<|>Hypertension is both a risk factor for developing AF and worsens its outcomes<|>8)\n##\n(\"relationship\"<|>STROKE<|>ATRIAL FIBRILLATION<|>AF significantly increases stroke risk which anticoagulation aims to prevent<|>9)\n##\n(\"relationship\"<|>THROMBOEMBOLISM<|>ATRIAL FIBRILLATION<|>AF increases thromboembolism risk requiring anticoagulation<|>9)\n##\n(\"relationship\"<|>BLEEDING<|>ATRIAL FIBRILLATION<|>Bleeding risk must be assessed when treating AF with anticoagulants<|>8)\n##\n(\"relationship\"<|>CHA2DS2-VASc<|>STROKE<|>CHA2DS2-VASc score predicts stroke risk in AF patients<|>9)\n##\n(\"relationship\"<|>HAS-BLED<|>BLEEDING<|>HAS-BLED score predicts bleeding risk in AF patients<|>9)\n##\n(\"relationship\"<|>HYPERTENSION<|>STROKE<|>Hypertension increases stroke risk in AF patients<|>8)\n##\n(\"relationship\"<|>HYPERTENSION<|>BLEEDING<|>Uncontrolled hypertension increases bleeding risk in AF patients<|>7)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558678, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 587, "prompt_tokens": 2834, "total_tokens": 3421, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2752}, "prompt_cache_hit_tokens": 2752, "prompt_cache_miss_tokens": 82}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 司匹林建议空腹服用以减少胃肠道  反应 ;③服用前有发生消化道出血的高危因素 ,如消化  道疾病(溃疡病及其并发症史) , 65岁以上 , 同时服用  皮质类固醇、抗凝药或非甾体类抗炎药等 ,应采取预防  措施 ,包括筛查与治疗幽门螺杆菌感染 ,预防性应用质  子泵抑制剂 , 以及采用合理联合抗栓药物的方案等 ;  ④合并活动性胃溃疡、严重肝病、肾功能衰竭、出血性  疾病者需慎用或停用阿司匹林 ; ⑤服用阿司匹林出现  严重胃肠出血者停用阿司匹林 ,按出血相关路径处理 ,  轻者可加用质子泵抑制剂治疗。\n5.3.4  心房颤动的抗凝治疗\n\n要点 5K   房颤的抗凝治疗\n　　　·具有血栓栓塞危险因素的高血压合并房颤患 者 ,应进行抗凝治疗( Ⅰ ,A) 。\n　　　·非瓣膜病房颤患者优先选择使用非维生素 K 拮抗类口服抗凝药( Ⅰ ,A) 。\n\n　　根据最新的流行病学数据 ,我国人群年龄校正后  的房颤患病率为男性 1.7% ,女性 1.6%[358] 。高血压  不但是发生房颤的重要危险因素[359]  ,也是非瓣膜病、 脑卒中和体循环栓塞的危险因素之一 。未控制的高血  压还是房颤患者出血的危险因素。\n　　筛查与评估 : 由于房颤可导致多种不良后果 ,而相  当部分的房颤患者没有症状 ,所以近年来十分重视对  房颤的筛查 ,特别强调对 65岁以上的患者进行机会性  筛查 ,可使用心电图、可穿戴设备以及具有房颤筛查功  能的电子血压计等[360] 。所有合并非瓣膜病房颤的高  血压患者都应根据 CHA2DS2-VASc[congestive heart failure, hypertension, age≥75(doubled) , diabetes,  stroke(doubled) , vasculardisease, age65-74,  and sex category(female)] 评分进行血栓栓塞的风险评  估 , 并 进 行 以 HAS-BLED[hypertension,  abnormal renalorliverfunction, stroke, bleeding, labileINR,  elderly(greaterthan 65yearsold) , drugsoralcohol]  为基础的出血风险的评估 ,这种评估应根据患者的病  情变化动态实施。\n　　治疗策略 :主要有三个方面 。①对有脑卒中风险 的患者进行抗凝治疗 ; ②实行节律或室率控制以控制 房颤的症状 ,改善生活质量 ;③基础疾病和危险因素的 治疗 。将三方面的治疗措施进行整体结构化管理 ,是 房颤治疗理念最近的趋势。\n凡是具有血栓栓塞危险因素的高血压合并房颤患\n\n\n　者 ,应按照现行指南进行抗凝治疗[\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>ASPIRIN<|>ORGANIZATION<|>Aspirin is a medication recommended to be taken on an empty stomach to reduce gastrointestinal reactions and has precautions for use in certain conditions like active gastric ulcers, severe liver disease, etc.\")\n##\n(\"entity\"<|>ATRIAL FIBRILLATION<|>EVENT<|>Atrial fibrillation is a condition with a prevalence of 1.7% in males and 1.6% in females in China, and is a significant risk factor for stroke and systemic embolism\")\n##\n(\"entity\"<|>CHA2DS2-VASc<|>ORGANIZATION<|>CHA2DS2-VASc is a scoring system used to assess the risk of thromboembolism in patients with non-valvular atrial fibrillation\")\n##\n(\"entity\"<|>HAS-BLED<|>ORGANIZATION<|>HAS-BLED is a scoring system used to assess the risk of bleeding in patients with atrial fibrillation\")\n##\n(\"relationship\"<|>ASPIRIN<|>ATRIAL FIBRILLATION<|>Aspirin may be used in the management of atrial fibrillation to reduce the risk of stroke<|>5)\n##\n(\"relationship\"<|>CHA2DS2-VASc<|>ATRIAL FIBRILLATION<|>CHA2DS2-VASc is used to evaluate thromboembolic risk in atrial fibrillation patients<|>8)\n##\n(\"relationship\"<|>HAS-BLED<|>ATRIAL FIBRILLATION<|>HAS-BLED is used to evaluate bleeding risk in atrial fibrillation patients<|>8)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_2445d9ae7f4a8a40cababd801ce7edbd651dbf12d7eef272c74bd3d89ec63456_v2"}